Retinal angiomatous proliferation or retinal anastomosis to the lesion

Eye

Volumn 24, Issue 3, 2010, Pages 491-496

  Scott, A W ^a   Bressler, S B ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Occult choroidalneovascularization; RAL; RAP; Retinal anastomosis to the lesion; Retinal angiomatous proliferation; Type 3 neovascularization

Indexed keywords

BEVACIZUMAB; PLACEBO; RANIBIZUMAB; TRIAMCINOLONE; VERTEPORFIN;

ANASTOMOSIS; CLINICAL TRIAL; CONFERENCE PAPER; FLUORESCENCE ANGIOGRAPHY; HUMAN; OPTICAL COHERENCE TOMOGRAPHY; PHOTODYNAMIC THERAPY; RETINA ANGIOMATOUS PROLIFERATION; RETINA HEMORRHAGE; RETINA MACULA AGE RELATED DEGENERATION; SUBRETINAL NEOVASCULARIZATION; TREATMENT RESPONSE; VISUAL ACUITY; VISUAL IMPAIRMENT;

EID: 77949445642     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2009.311     Document Type: Conference Paper

References (26)

1. Kuhn D, Meunier I, Soubrane G, Coscas G. Imaging of chorioretinal anastamoses in vascularized retinal pigment epithelial detachments. Arch Ophthalmol 1995; 113: 1392-1398.
2. Freund KB, Klais CM, Eandi CM, Ober MD, Goldberg DE, Sorenson JA et al. Sequenced combined intravitreal triamcinolone and indocyanine green angiography-guided photodynamic therapy for retinal angiomatous proliferation. Arch Ophthalmol 2006; 124: 487-492.
3. Hartnett ME, Weiter JJ, Gardts A, Jalkh AE. Classification of retinal pigment epithelial detachments associated with drusen. Graefes Arch Clin Exp Ophthalmol 1992; 230: 11-19.
4. Gass JD. Stereoscopic Atlas of Macular Diseases. 4th ed. CV Mosby: St Louis, 1997; 26-30.
5. Freund KB, Ho I, Barbazetto IA, Koizumi H, Laud K, Ferrara D et al. Type 3 neovascularization: the expanded spectrum of retinal angiomatous proliferation. Retina 2008; 28: 208-211.
6. Yannuzzi LA, Freund KB, Takahashi BS. Editorial: review of retinal angiomatous proliferation of type 3 neovascularization. Retina 2008; 28: 375-384.
7. Yannuzzi LA, Negrao S, Iida T, Carvalho C, Rodriguez-Coleman H, Slakter J et al. Retinal angiomatous proliferation in age-related macular degeneration. Retina 2001; 21: 416-434.
8. Gass JD, Agarwal A, Lavina AM, Tawansy KA. Focal inner retinal hemorrhages in patients with drusen: an early sign of occult choroidal neovascularization and chrorioretinal anastomosis. Retina 2003; 23: 741-751.
9. Borrillo JL, Sivalingam A, Martidis A, Federman JL. Surgical ablation of retinal angiomatous proliferation. Arch Ophthalmol 2003; 121: 558-561.
10. Ghazi NG, Knape RM, Kirk TQ, Tiedeman JS, Conway BP. Intravitreal bevacizumab (Avastin) treatment of retinal angiomatous proliferation. Retina 2008; 28: 689-695.
11. Verteporfin in Photodynamic Therapy Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-Verteporfin in Photodynamic Therapy report 2. Am J Ophthalmol 2001; 131: 541-560.
12. Hartnett ME, Weiter JJ, Staurenghi G, Elsner AE. Deep retinal vascular anomalous complexes in advanced age-related macular degeneration. Ophthalmology 1996; 103: 2042-2053.
13. Bottoni F, Massacesi A, Cigada M, Viola F, Muicco I, Staurenghi G. Treatment of retinal angiomatous proliferation in age-related macular degeneration. Arch Ophthalmol 2005; 123: 1644-1650.
14. Kusserow C, Michels S, Kollner T, Schmidt-Erfurth U. Impact of chorioretinal anastomosis on prognosis in photodynamic therapy [ARVO abstract]. Invest Ophthalmol Vis Sci 2001; 42: 512. Abstract 2761.
15. Bressler NM. Retinal anastomosis to choroidal neovascularization: a bum rap for a difficult disease. Arch Ophthalmol 2005; 123: 1741-1743.
16. Viola F, Massacesi A, Orzalesi N, Ratiglia R, Staurenghi G. Retinal angiomatous proliferation: natural history and progression of vision loss. Retina 2009; 29: 732-739.
17. Koizumi H, Iida T, Saito M, Nagayama D, Maruko I. Choroidal circulatory disturbances associated with retinal angiomatous proliferation on indocyanine green angiography. Graefes Arch Clin Exp Ophthalmol 2008; 2246: 515-520.
18. Monson DM, Smith JR, Klein ML, Wilson DJ. Clinicopathologic correlation of retinal angiomatous proliferation. Arch Ophthalmol 2008; 126: 1664-1668.
19. Meyerle CB, Freund B, Iturralde D, Spaide RF, Sorenson JA, Slakter JS et al. Intravitreal bevacizumab (Avastin) for retinal angiomatous proliferation. Retina 2007; 27: 451-457.
20. Joeres S, Heussen FM, Treziak T, Bopp S, Joussen AM. Bevacizumab (Avastin) treatment in patients with retinal angiomatous proliferation. Graefes Arch Clin Exp Ophthalmol 2007; 245: 1597-1602.
21. Gharbiya M, Allievi F, Recupero V, Martini D, Mazzeo L, Gabrieli CB. Intravitreal bevacizumab as primary treatment for retinal angiomatous proliferation: twelve-month results. Retina 2009; 29: 740-749.
22. Lai TY, Chan WM, Liu DT, Lam DS. Ranibizumab for retinal angiomatous proliferation in neovascular age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 2007; 245: 1877-1880.
23. Konstantinidis L, Mameletzi E, Mantel I, Pournaras J-A, Zografos L, Ambresin A. Intravitreal ranibizumab (Lucentis) in the treatment of retinal angiomatous proliferation (RAP). Graefes Arch Clin Exp Ophthalmol 2009; 247: 1165-1171.
24. Lalwani GA, Rosenfeld PJ, Fung AE, Dubovy SR, Michels S, Feuer W et al. A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study. Am J Ophthalmol 2009; 148: 1-3.
25. Lo-Giudice G, Gismondi M, De Belvis V, Clan R, Tavolato M, Galan A. Single-session photodynamic therapy combined with intravitreal bevacizumab for retinal angiomatous proliferation. Retina 2009; 29: 949-955.
26. Rouvas AA, Papakostas TD, Vavvas D, Vergados I, Moschos MM, Kotsolis A et al. Intravitreal ranibizumab, intravitreal ranibizumab with PDT, and intravitreal triamcinolone with PDT for the treatment of retinal angiomatous proliferation: a prospective study. Retina 2009; 29: 536-544.